Erythropoietin (EP) mRNA was measured in normal and anemic mice during fetal and postnatal development. Normal fetal livers at 14 d of gestation contained a low level of EP mRNA. By day 19 of gestation, no EP mRNA was detected in normal or anemic fetal livers or normal fetal kidneys, but anemic fetal kidneys had low levels of EP mRNA. Newborn through adult stage mice responded to anemia by accumulating renal and hepatic EP mRNA. However, total liver EP mRNA was considerably less than that of the kidneys. Juvenile animals, 1-4 wk old, were hyperresponsive to anemia in that they produced more EP mRNA than adults. Moreover, nonanemic juveniles had readily measured renal EP mRNA, whereas the adult level was at the lower limit of detection. Because of the very low level of fetal EP mRNA, placental transfer of EP was evaluated. When administered to the pregnant mouse, r25I-EP was transferred in significant amounts to the fetuses. These results indicate that in mice the kidney is the main organ of EP production at all stages of postnatal development and that adult kidney may also play some role in providing EP for fetal erythropoiesis via placental transfer of maternal hormone.
Introduction
Erythropoietin (EP)' is a glycoprotein hormone that regulates the terminal stages of mammalian erythropoiesis. The source ofEP in the body has been previously sought by measuring the hormone in various tissues using either bioassays or radioimmunoassays. Although these studies may have indicated where EP is located or stored in the body, the identification of the tissues that produce EP requires other experimental approaches. The recent clonings of the murine EP gene (1, 2) have provided probes with which to identify the organs involved in EP production by measuring their content of mRNA coding for EP. We have found in anemic adult mice that -85-90% of EP mRNA is in the kidneys and 10-15% is in the liver (3) . Others have found a more equal EP mRNA distribution between liver and kidneys in cobalt-treated rats (4) .
An important issue that is not yet understood is the source of EP during prenatal and early postnatal development. The production of EP during fetal and postnatal development has been examined mainly in sheep and rats. EP assays in nephrectomized and/or hepatectomized sheep (5, 6) suggested that the livers of the anemic fetuses accounted for almost all of the EP until late in gestation when the kidneys accounted for a small portion of the total fetal EP. Through birth and the neonatal period the kidneys accounted for an ever-increasing portion of the total EP in anemic sheep. Similar types of experiments using hypoxic, neonatal rats, found that the kidneys appeared to account for little of the EP that could be bioassayed in the plasma in the first few days of life (7) (8) (9) . After the neonatal period, however, the kidneys produced progressively greater amounts of EP during the first four weeks of life. In hypoxic rats three weeks old or less, Gruber et al. (7) suggested that the liver was responsible for some production ofEP. However, no EP was detected by Fried et al. (8) or Caro et al. (9) in bioassays of EP in the livers of hypoxic newborn and developing rats. A more recent study using radioimmunoassays (10) in hypoxic fetal and neonatal rats suggested that the major portion of EP is produced by some tissue other than kidneys or liver in mid-gestation, by the liver in later gestation, and by the kidneys just before birth and during postnatal development. Any transplacental contribution of maternally produced EP to the fetus in these sheep and rat studies could not be determined. Although some studies examining the possible fetal responses to the transfer of EP from the mother did not support such a transfer (1 1, 12), the direct measurement of fetal mouse EP activity after administration of large doses of EP to the mother did indicate that some placental transfer does occur (13) . The recent availability of large amounts of pure recombinant EP, which can be radiolabeled, provides a new tool to study placental transfer of EP.
We report here the analysis of EP mRNAs to determine which tissues produce EP in normal and anemic mice during fetal and postnatal development. Using '25I-labeled EP, we also examine the placental transfer ofEP from mother to fetus.
Methods
Mice. Normal and timed pregnant BALB/c mice were purchased from Cumberland View Farms, Clinton, TN. Anemia was induced in mice either by removal of 0.5 ml of blood under ether anesthesia or by intraperitoneal injection of from 40 to 75 Aig of phenylhydrazine hydrochloride per gram of body weight. Bled mice were volume repleted with 0.5 ml of isotonic saline. These treatments were done at 36, 24, and 12 h before sacrifice. Hematocrits were determined just prior to sacrifice, and those mice with hematocrits of 16-22% were used as anemic mice. Normal controls had hematocrits ranging from 46 to 50% for adults (60 d old), 33-37% for newborns, 32-35% in 9-d-olds, 29-33% in 16-d-olds, and 38-42% in 30-d-olds. For fetal studies, the gestational ages were determined by vaginal plugging with the morning of the plug designated as day 1 and the day of birth as day 20. Fetal anemia was induced by maternal injection of phenylhydrazine as in the above schedule. Due to fetal loss when the maternal hematocrits were reduced below 24%, the phenylhydrazine dosage was reduced to achieve 25-28% hematocrits. Fetal hematocrits on day 18 or 19 of gestation were also reduced to 25-28% with this treatment while normal fetal hematocrits were 34-38%.
Analyses ofEP mRNA. For tissue RNA isolation, kidneys or livers were pooled separately from groups of animals of the following numbers: (a) animals 2 wk old or older, groups of 6 to 12; (b) animals 1 wk old, groups of 10 to 24; (c) newborn animals, groups of 20 to 35; (d) fetuses, groups of 40 to 77. Total RNAs from the mouse organs were obtained by homogenization in 4 M guanidine thiocyanate'and sedimentation through 5.7 M CsCI as in the method ofChirgwin et al. (I 1). Polyadenylated RNAs were isolated from total RNAs by chromatographic separation with oligo (dT)-cellulose. From 1 to 6 mg of total RNA was isolated from each pool oforgans and for isolation ofpolyadenylated RNAs, typically 1 mg oftotal RNA was loaded onto a column (1 cm diam by 3 cm length) of type 3-oligo (dT)-cellulose (Collaborative Research, Lexington, MA). The quantities of RNAs were determined by absorbance measurements at 260 nm, and the samples were aliquoted and stored as alcohol precipitates in 1.5 ml microcentrifuge tubes pending analysis. The RNAs were separated by electrophoresis on formaldehyde-1.5% agarose gels (15) and blotted onto nitrocellulose sheets.
The blotted RNAs were hybridized (16) Several steps were taken to ensure that the stated amounts of RNA were actually loaded onto each gel lane and that this RNA was intact and transferred uniformly to the nitrocellulose blots. Firstly, the equivalence of total cellular RNA samples to be loaded onto a gel was confirmed by running "mini" formaldehyde-agarose gels of 5-,g portions of each sample and staining the gels with ethidium bromide to compare the 28 S and 18 S ribosomal RNAs. And after analysis ofthe Northern blot with the EP specific probe, this probe was removed by immersing the blot in 0.015 M NaCl, 0.0015 M sodium citrate for 10 min at 85SC, and the same blot was rehybridized with a nick-translated DNA probe specific for cytoplasmic actin (18) . Finally after a second round ofprobe removal, the blots containing total cellular RNAs were hybridized with a probe specific for 28 S ribosomal RNA (18) . Hybridization of the total cell 'RNA blots with the ribosomal RNA probe (not shown) revealed that similar amounts oftotal RNA were present on all lanes of these blots, and these controls coupled with the hybridization of the actin probe on all blots, including those containing polyadenylated RNAs, showed that all lanes contained undegraded RNAs in the appropriate amounts.
Messenger RNA for EP was also detected by RNase protection assays. A Analysis of maternal-fetal transfer of '25I-EP. To measure maternal-fetal transfer of EP, day 19 pregnant mice were given 5 X 106 cpm (1.125 U) of 251I-EP via tail vein injection. The EP was pure recombinant human EP (129,000 U/mg; AMGen Biologicals, Thousand Oaks, CA) which was iodinated with Nal25I using Jodo-Gen (Pierce Chemicals, Rockford, IL) as previously described (20) . Over 95% of the biological activity of EP was retained after iodination. The pregnant mice were sacrificed at 1, 3, 6, and 10 h following the I251-EP injection and their fetuses removed. Blood samples were obtained from the pregnant mice immediately before sacrifice. Each fetus was separated from its surrounding membranes, clamped at the umbilical cord, rinsed in three changes of fresh isotonic saline to remove any maternal blood, blotted dry, and fetal blood recovered by jugular vein laceration. The percentage oftotal 1251 in the form of '251-EP was determined by taking the sera from the blood samples and separating them on a TSK-3000 high pressure gel permeation column (Bio-Rad Labs, Richmond, CA).
As a confirmation that all ofthe counts associated with high molecular weight material in the serum samples were in I251-EP, aliquots of sera were separated by SDS-PAGE (21).
Results
Accumilation ofEP mRNA in mouse organs duringfetal and postnatal development. (Fig. 2 B) , whereas the mRNA levels from anemic tissues of other postnatal stages could be seen using total RNA. Using Northern blots, the only sample other than those from anemic postnatal animals which was positive for EP mRNA was the polyadenylated RNA from kidneys of 30-d-old normal animals ( Fig. 1 C) . Actin probe hybridization on blots ofFigs. 1 and 2 serves as a control for insuring that intact RNA was transferred on the lanes. Actin mRNA levels in the kidneys are high in newborns and very young animals, and the levels drop as the animal's age increases, reaching a much lower level in adult mice (Fig.  1, A-C) . Note that animals of comparable age, whether anemic or normal, have comparable levels of actin mRNA in the kidneys. Also, actin mRNA was present in the same relative proportions among samples on the blots containing total cellular RNAs as on those containing polyadenylated RNAs. The levels ofactin mRNA in livers ofdeveloping animals also show progressive decrease during the first few weeks after birth although the changes in the liver are not as drastic as those seen in the kidneys (Fig. 2, A and B) . This developmental pattern for actin mRNA in liver was reported earlier (18) .
To further investigate EP mRNA levels in those tissues which showed no or weak signals on Northern blots, a more sensitive RNase protection assay was used (Fig. 3) with a labeled RNA probe that included exons 2-4 ofthe EP gene. The three exons, which are protected from RNase in Fig. 3 , are indicated at lengths of 180, 143, and 87 bases. A fourth band on the gel is marked by an asterisk at a length of 1 (Fig. 3 B) . Whole fetuses minus the fetal livers at day 14 of gestation were negative for EP mnRNA (lane WE in Fig. 3 B) as were the placentas (data not shown) from these fetuses. At day 19 of gestation, the fetal kidney responded to anemia by accumulating EP mRNA, while no EP mRNA was detected in the anemic fetal liver (Fig. 3 B) . These results suggest that the kidney has become the most responsive organ to anemia in the fetus at one day after it can be identified macroscopically. 24d postnatal, anemic mice have both renal and hepatic EP mRNA (Figs. 1 and 2) . In Table I , the amount of EP mnRNA per microgram of total RNA in the 24d-old anemic mouse kidney is one fourth, and in the liver one half, of that found in the respective organs of an anemic, young adult (60-d-old) mouse with a similar hematocrit. At 9 d of age, the anemic mouse raises its renal EP mRNA per microgram RNA to twice that found in the anemic adult kidney and its hepatic EP mRNA to eight times that found in the anemic adult liver (Table I ). This relatively increased response to anemia by accumulation of EP mRNA per microgram RNA continues through 16 d of age and reaches values in the kidneys and livers of anemic 30-d-old mice which are five times more than the respective anemic adult organs. It is only around this 30-d postnatal period that EP mRNA could be detected by Northern blotting in the kidneys of normal mice (Fig. 1 C) although by the RNase protection assay EP mRNA was detected in normal animals at 9, 16, and 22 d of age as well (Fig.  3 A) . The EP mRNA level in nonanemic adult (60-d-old) kidneys is at the lower limit of detection by RNase protection. An extremely faint band at the 180-base exon position can be seen in the NK lane of Fig. 3 when exposure time is increased fourfold over the exposure shown. By densitometry of variable duration exposures this NK signal is about 0.002 of the signal from anemic 60-d-old mice (Table I) . Therefore, an 500-fold increase in EP mRNA appears to occur with the induced anemia in adult mice. A much more accurate comparison between the normal and anemic levels of kidney EP mRNA can be made in the case ofthe 30-d postnatal mouse where the anemic mouse has a value 5.26 and the normal has a value of 0.037 (see Table I ). Thus, a greater than 140-fold increase in renal EP mRNA occurs when the hematocrit is lowered to the 16-22% range in these mice.
From the relative amounts of EP mRNA per microgram total RNA and the total RNAs recovered from livers and kidneys at the various ages, the distribution of total EP mRNA between the kidneys and liver can be assessed during murine development (Table I ). The total cellular RNA in newborn liver is approximately 10 times as much as in both kidneys. However, the kidneys develop rapidly, and by 30 d of postnatal life the adult ratio of about five times as much hepatic as renal total RNA is achieved (Table I footnote) . In anemic mice, the kidneys account for about 75% of the total EP mRNA in the first 2 wk of postnatal life, while by 30 d of age and later they account for about 90% of the EP mRNA detected (Table I) .
Transfer ofmaternal EP to thefetus. The possible transfer of EP from the mother to the fetus via the placenta was investigated by giving day 19 pregnant mice a single intravenous injection of 5 X IO' cpm of '25I-EP. This amount represented a total of 1.125 biological units of EP per mouse. At various times after the injections, the pregnant mice were sacrificed and maternal and fetal blood samples taken. Aliquots of sera from the blood samples were separated on a TSK-3000 column to determine the proportion of total counts per minute in iodinated EP as opposed to iodotyrosine or iodide. When the sera were separated on SDS-polyacrylamide gels, a single 35,000 molecular weight band migrating identically to '25I-EP was recovered. The 1251I-EP crossed the murine placenta and achieved concentrations in the fetal blood of from 7 to 10% of that found in the maternal blood at the same time (Fig. 4) . The '251I-EP had similar disappearance rates in the maternal and fetal blood. During the 10 h after the injection of the pregnant mice, the half-life of 1251I-EP is 6 h in both maternal and fetal circulations (Fig. 4) . at gestational day 14. Despite testing multiple groups of fetuses, no EP mRNA was detectable in fetal livers on days 16 through 19 of gestation, even when the fetuses were rendered moderately anemic (hematocrits of 25-28%) by phenylhydrazine treatment of the mother. However, it is not clear how hypoxic these fetuses become in comparison to postnatal animals of similar hematocrits. Thus, our results indicate that the murine fetal liver is a source of EP during the mid-gestational period of development but by late gestation it has much less of a role in EP production. Indeed, during late gestation, the kidneys responded to anemia by synthesizing slight but detectable EP mRNA while no EP mRNA was detected in the liver. These findings suggest an apparent difference in the significance of the liver during late gestation and the early neonatal period between sheep (5, 6) and mice. This probably reflects species differences in the timing of organ maturation during development. One cannot assess the relative degrees of hypoxia of the murine liver tissues at gestational day 14 versus gestational day 19, so it is not possible to distinguish whether it is the stimulus or the capacity of the liver to respond which leads to the observed differences in EP mRNA accumulated. Although the EP mRNA in the gestational day 14 liver is relatively low (TableI), the liver is the major site of erythropoiesis at this stage of fetal development. Thus, the local levels of EP in the gestational day 14 liver may be quite elevated as compared to other tissues. The results of this work do demonstrate that the accumulation of EP mRNA in response to the same degree of anemia is increased dramatically as the developing mouse progresses from a fetus 1 d before birth to a newborn 2 d after birth (compare lanes f and2' in Fig. 1 A) . Furthermore, this responsiveness continues to increase dramatically during the first 4 wk of life, and later decreases somewhat to the adult state. The results in Fig. 4 shows that some EP is transferred from the mother to the fetuses. At all times tested after maternal injection of'25-labeled EP (1-10 h), the '251-EP concentration in fetal blood was about 7-10% of the level in maternal blood. However, in both mice and humans, the fetal erythroid progenitor cells have been shown to be more sensitive to EP than those of adults (26, 27) and, therefore, this lower level of EP in fetal blood may be sufficient for a normal fetal erythropoietic response. The amount of'251I-EP administered to the pregnant mice resulted in EP blood levels which were higher than normal, an estimated 250 mU/ml immediately after injection and a measured 90 mU/ml at 1 h postinjection. However, these values are within the range achieved in mild to moderate anemia and are much less than those seen in severe anemia (9, 10) . Since iodination of EP to higher specific activities than that used here destroys binding and biological activity (20) , placental transfer of EP at basal physiological levels cannot be evaluated in mice. However, the placental transfer of EP in conditions similar to mild anemia suggest that it may have a physiological role in fetal erythropoiesis. Preliminary work in our laboratory indicates that '25I-EP binds specifically to receptors on the murine placenta (unpublished results). Although these preliminary results suggest that placental receptors for EP may be involved in transfer of EP from the mother to fetus during late gestation, further studies will be required to prove this transfer function.
The data presented here show that in the mouse (a) the fetal liver produces low levels of EP mRNA during mid-gestation that decline during late gestation, (b) by the last day of gestation, the fetal kidney is responsive to anemia by EP mRNA production, (c) the kidney is the main organ of EP production at all stages of postnatal development, and (d) the maternal kidney may play a role in providing some proportion of the EP for fetal erythropoiesis via placental transfer of maternal hormone.
